ArticleNeuroSci2025
Psychosocial Correlates of Insomnia Symptoms Among Women and Men Receiving Buprenorphine Treatment for Opioid Use Disorder.
Sajanee Chithranjan, Michelle Eglovitch, Madison M Marcus, Dace Svikis, Maha Alattar, Caitlin E Martin
Abstract read
In one paragraphArticle in NeuroSci, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Sajanee ChithranjanDepartment of Obstetrics and Gynecology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Michelle EglovitchDepartment of Psychology, College of Humanities and Sciences, Virginia Commonwealth University, Richmond, VA 23284, USA.ORCID 0009-0006-0887-9461 Madison M MarcusDepartment of Obstetrics and Gynecology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.ORCID 0000-0002-8403-5395 Dace SvikisDepartment of Psychology, College of Humanities and Sciences, Virginia Commonwealth University, Richmond, VA 23284, USA.
Maha AlattarDepartment of Neurology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Caitlin E MartinDepartment of Obstetrics and Gynecology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.ORCID 0000-0001-5560-458X Funding
Research Supplement to Promote Diversity in Health Related ResearchUL1TR002649 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2018 to 2022
$19.1MWright Regional Center for Clinical and Translational ScienceUM1TR004360 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI FREDERICK Gerard MOELLER · 2023 to 2026
$16.3MTRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7MNeurofunctional phenotyping to investigate the role of the orexin system at the intersection of opioid use disorder and insomniaR01DA059483 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Caitlin Eileen Martin · 2024 to 2026
$2.3MAdaptation and Refinement of a Clinically Applicable Phenotypic Battery to Individualize Opioid Use Disorder Treatment for Women Through the Postpartum PeriodK23DA053507 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI MARTIN, CAITLIN EILEEN · 2021 to 2025
$1.0MHealth equity informed delivery of cognitive behavioral therapy for insomnia adapted for individuals with opioid use disorderR34DA058494 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Caitlin Eileen Martin · 2024 to 2026
$699kNCATS NIH HHS UL1 TR002649NCATS NIH HHS UL1TR002649NCATS NIH HHS UM1 TR004360NIDA NIH HHS K23 DA053507NIDA NIH HHS R01 DA059483NIDA NIH HHS R01DA059483NIDA NIH HHS R34 DA058494NIDA NIH HHS R34DA058494NIDA NIH HHS T32 DA007027NIDA NIH HHS T32DA007027; K23DA053507
6 · The paper itselfAbstract
Insomnia is common in individuals with opioid use disorder (OUD). Biopsychosocial factors are important in sleep health, yet this intersection has yet to be fully elucidated in people on buprenorphine for OUD. The objective is to report on patient-reported biopsychosocial factors among people with and without insomnia, specifically among women and men in outpatient OUD treatment. The parent study enrolled adults stabilized on buprenorphine from February 2022-September 2023. Scores of ≥11 on the Insomnia Severity Index (ISI) indicated clinically significant insomnia. Differences were detected by the presence of insomnia, stratified by men and women, using chi-squared and Fisher's exact tests. Of the overall participants (N = 130), most (
Indexed as
buprenorphineinsomniasleep disturbancesubstance use disorders
Identifiers
PMID40559209
PMCPMC12195933
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390